FDA — authorised 11 December 1974
- Application: ANDA080880
- Marketing authorisation holder: IMPAX LABS
- Indication: Labeling
- Status: approved
🇺🇸 CHLOROQUINE PHOSPHATE in United States
FDA authorised CHLOROQUINE PHOSPHATE on 11 December 1974
Marketing authorisations
FDA — authorised 13 January 1982
- Application: ANDA087504
- Marketing authorisation holder: TEVA
- Local brand name: CHLOROQUINE PHOSPHATE
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 21 December 1982
- Application: ANDA088030
- Marketing authorisation holder: WATSON LABS
- Local brand name: CHLOROQUINE PHOSPHATE
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 21 December 1982
- Application: ANDA087979
- Marketing authorisation holder: WATSON LABS
- Local brand name: CHLOROQUINE PHOSPHATE
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 29 August 2003
- Application: ANDA040516
- Marketing authorisation holder: IMPAX LABS
- Local brand name: CHLOROQUINE PHOSPHATE
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 3 December 2009
- Application: ANDA090249
- Marketing authorisation holder: IPCA LABS LTD
- Local brand name: CHLOROQUINE PHOSPHATE
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 21 January 2011
- Application: ANDA091621
- Marketing authorisation holder: NATCO PHARMA LTD
- Status: approved
FDA — authorised 21 January 2011
- Application: ANDA090612
- Marketing authorisation holder: NATCO PHARMA LTD
- Indication: Labeling
- Status: approved
FDA — authorised 3 September 2021
- Application: ANDA214756
- Marketing authorisation holder: SUVEN PHARMS
- Indication: Manufacturing (CMC)
- Status: approved
FDA
- Application: ANDA087228
- Marketing authorisation holder: MD PHARM
- Local brand name: CHLOROQUINE PHOSPHATE
- Indication: TABLET — ORAL
- Status: approved
CHLOROQUINE PHOSPHATE in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is CHLOROQUINE PHOSPHATE approved in United States?
Yes. FDA authorised it on 11 December 1974; FDA authorised it on 13 January 1982; FDA authorised it on 21 December 1982.
Who is the marketing authorisation holder for CHLOROQUINE PHOSPHATE in United States?
IMPAX LABS holds the US marketing authorisation.